ELIA, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 2.668
EU - Europa 1.320
AS - Asia 376
AF - Africa 97
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.469
Nazione #
US - Stati Uniti d'America 2.634
IT - Italia 635
SE - Svezia 384
CN - Cina 131
BG - Bulgaria 126
VN - Vietnam 92
SG - Singapore 78
DE - Germania 66
CI - Costa d'Avorio 50
CA - Canada 32
GB - Regno Unito 29
SN - Senegal 25
HK - Hong Kong 23
IQ - Iraq 19
NG - Nigeria 19
RU - Federazione Russa 17
IN - India 12
PL - Polonia 11
UA - Ucraina 11
FR - Francia 9
FI - Finlandia 8
TR - Turchia 8
CH - Svizzera 5
GR - Grecia 5
ES - Italia 4
AT - Austria 3
AU - Australia 3
CZ - Repubblica Ceca 3
IR - Iran 3
JP - Giappone 3
MX - Messico 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
IL - Israele 1
KE - Kenya 1
LK - Sri Lanka 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 4.469
Città #
Fairfield 441
Woodbridge 249
Chandler 229
Ashburn 209
Milan 197
Houston 177
Seattle 173
Cambridge 155
Wilmington 144
Serra 140
Sofia 126
Ann Arbor 124
New York 91
Princeton 80
Lawrence 54
Abidjan 50
Medford 48
Beijing 45
Florence 38
Pisa 30
Dong Ket 28
Ottawa 27
Rome 27
Boulder 26
Dakar 25
Hong Kong 23
Redwood City 23
San Diego 23
Des Moines 22
Bremen 20
Frankfurt am Main 20
Nanjing 20
Lagos 19
Sulaymaniyah 18
Dearborn 17
Carrara 14
Los Angeles 13
Norwalk 13
Washington 11
London 10
Warsaw 9
Tianjin 8
Guangzhou 7
Chengdu 6
Hebei 6
Jacksonville 6
Bern 5
Livorno 5
Nanchang 5
Ogden 5
Changsha 4
Fremont 4
Kilburn 4
Kunming 4
San Francisco 4
Serpukhov 4
Shenyang 4
St Petersburg 4
Agliana 3
Dallas 3
Izmir 3
Jiaxing 3
Lucca 3
Pomezia 3
Vienna 3
Wuhan 3
Zhengzhou 3
Absecon 2
Alexandria 2
Bedford 2
Boardman 2
Boston 2
Capaccio 2
Cascina 2
Castano Primo 2
Cavriglia 2
Esslingen am Neckar 2
Gabbro 2
Grosseto 2
Hefei 2
Islington 2
Massa 2
Naples 2
Pescara 2
Phoenix 2
Sant'Anastasia 2
Siena 2
Thornhill 2
Tokyo 2
Viterbo 2
Acton 1
Altopascio 1
Amsterdam 1
Ankara 1
Ardabil 1
Arezzo 1
Azogues 1
Bengaluru 1
Bhubaneswar 1
Bogotá 1
Totale 3.376
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 138
Mechanostructure and composition of highly reproducible decellularized liver matrices 135
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 129
Characterisation of liver matrices 123
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 118
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 118
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 112
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 111
Liver derived decellularised matrices in bioreactors 103
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 103
Novel treatment options for anaplastic thyroid cancer 100
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 100
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 99
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 99
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 98
Liver decellularised matrices in Quasi-Vivo® bioreactors as in-vitro models of hepatic metabolism 97
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 91
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 91
Novel therapies for thyroid autoimmune diseases: An update 91
Novel Therapies for Thyroid Autoimmune Diseases 89
Molecular testing in the diagnosis of differentiated thyroid carcinomas 88
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 88
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 88
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 82
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 82
New insight in endocrine-related adverse events associated to immune checkpoint blockade 82
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 81
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 81
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 81
Chemokines in hyperthyroidism 78
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 78
The protective effect of myo-inositol on human thyrocytes 77
Novel treatments for anaplastic thyroid carcinoma 77
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 77
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 76
Immune and inflammatory cells in thyroid cancer microenvironment 75
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 74
Th1 chemokines in autoimmune endocrine disorders 72
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 70
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up 68
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 67
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results 63
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 61
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 59
The COVID-19, epidemiology, clinic and prevention 58
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 57
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 56
Thyroid autoimmune disorders and cancer 53
Endocrine disruptors and thyroid autoimmunity 49
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 46
L-T4 Therapy in Enteric Malabsorptive Disorders 45
Precision Medicine in Graves’ Disease and Ophthalmopathy 44
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 39
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 37
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 35
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 31
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 30
Myoinositol in Autoimmune Thyroiditis 24
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 24
High risk of brain tumors in military personnel: a case control study 23
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 21
Molecular features of aggressive thyroid cancer 21
Teprotumumab for the treatment of thyroid eye disease 16
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 15
Chemokines in thyroid autoimmunity 14
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 14
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 12
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 11
Thyroid Metastasis from Primary Breast Cancer 9
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 5
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 4
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 3
Thyroid Autoimmunity and SARS-CoV-2 Infection 3
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 1
Totale 4.770
Categoria #
all - tutte 14.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019153 0 0 0 0 0 0 0 0 0 0 85 68
2019/20201.120 106 44 100 56 75 103 116 122 206 79 76 37
2020/2021545 39 58 70 15 23 25 19 60 34 68 25 109
2021/2022798 17 16 31 48 122 102 32 36 70 66 62 196
2022/2023901 134 128 73 53 74 103 38 53 153 6 66 20
2023/2024841 81 93 136 111 141 155 65 23 14 21 1 0
Totale 4.770